top of page
SynaptixBio_TEXTURE_2_purple_light-bkgrnd_D.png

Dan Williams welcomes news that NICE has raised the cost-effectiveness threshold for ultra-rare disease drugs

  • Writer: Dr Dan Williams
    Dr Dan Williams
  • Oct 8
  • 1 min read

Read the article on how ultra-rare disease drugs are getting a boost from NICE guidelines here>



NICE has raised the cost-effectiveness threshold for ultra-rare disease drugs

 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page